RAD51 and malignant colon neoplasm: The investigation on RAD51 and XRCC2 gene polymorphism was done by being encouraged with strong association between these genes and these gene polymorphisms may be used in several areas in colon cancer management, such as early detection of the carcinogenesis, prediction of tumor biologic behaviour and being a candidate therapeutic target for colon cancer.